Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (281-290 of 999) with videos related to

Pageof 100
Sort By:
The American Journal of Cardiology|December 13, 2016
Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)Lori Mosca, Christie M Ballantyne, Harold E Bays, et al.
Vascular Medicine (London, England)|February 22, 2014
Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE)Aaron R Folsom, Pamela L Lutsey, Vijay Nambi, et al.
Journal of the American College of Cardiology|April 26, 2008
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled studyEmile R Mohler, Christie M Ballantyne, Michael H Davidson, et al.
Diabetes|February 12, 2013
sRAGE and risk of diabetes, cardiovascular disease, and deathElizabeth Selvin, Marc K Halushka, Andreea M Rawlings, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
Metabolomic Pattern Predicts Incident Coronary Heart DiseaseZhe Wang, Cong Zhu, Vijay Nambi, et al.
Journal of Women'S Health (2002)|March 28, 2018
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial SubanalysisEliot A Brinton, Christie M Ballantyne, John R Guyton, et al.
Atherosclerosis|March 14, 2007
Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities StudyShun Kohsaka, Kelly A Volcik, Aaron R Folsom, et al.
European Journal of Preventive Cardiology|July 23, 2024
Early-onset atherosclerotic cardiovascular diseaseIdine Mousavi, John Suffredini, Salim S Virani, et al.
Atherosclerosis|November 16, 2005
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities studyRon C Hoogeveen, Alanna Morrison, Eric Boerwinkle, et al.
Circulation|September 10, 2015
Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the ElderlyAmil M Shah, Brian Claggett, Aaron R Folsom, et al.
Pageof 100

Showing results (281-290 of 999) with videos related to

Sort By:
Pageof 100
The American Journal of Cardiology|December 13, 2016
Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)Lori Mosca, Christie M Ballantyne, Harold E Bays, et al.
Vascular Medicine (London, England)|February 22, 2014
Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE)Aaron R Folsom, Pamela L Lutsey, Vijay Nambi, et al.
Journal of the American College of Cardiology|April 26, 2008
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled studyEmile R Mohler, Christie M Ballantyne, Michael H Davidson, et al.
Diabetes|February 12, 2013
sRAGE and risk of diabetes, cardiovascular disease, and deathElizabeth Selvin, Marc K Halushka, Andreea M Rawlings, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
Metabolomic Pattern Predicts Incident Coronary Heart DiseaseZhe Wang, Cong Zhu, Vijay Nambi, et al.
Journal of Women'S Health (2002)|March 28, 2018
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial SubanalysisEliot A Brinton, Christie M Ballantyne, John R Guyton, et al.
Atherosclerosis|March 14, 2007
Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities StudyShun Kohsaka, Kelly A Volcik, Aaron R Folsom, et al.
European Journal of Preventive Cardiology|July 23, 2024
Early-onset atherosclerotic cardiovascular diseaseIdine Mousavi, John Suffredini, Salim S Virani, et al.
Atherosclerosis|November 16, 2005
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities studyRon C Hoogeveen, Alanna Morrison, Eric Boerwinkle, et al.
Circulation|September 10, 2015
Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the ElderlyAmil M Shah, Brian Claggett, Aaron R Folsom, et al.
Pageof 100